Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022
Research

Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020

Marta BesComments to Author , Maria I. Costafreda, Mar Riveiro-Barciela, Maria Piron, Angie Rico, Josep Quer, Lluis Puig, and Silvia Sauleda
Author affiliations: Instituto de Salud Carlos III, Madrid, Spain (M. Bes, M.I. Costafreda, M. Riveiro-Barciela, M. Piron, A. Rico, J. Quer, L. Puig, S. Sauleda); Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain (M. Bes, M.I. Costafreda, M. Riveiro-Barciela, M. Piron, A. Rico, J. Quer, L. Puig, S. Sauleda); Banc de Sang i Teixits, Catalonia, Spain (M. Bes, M.I. Costafreda, M. Piron, A. Rico, L. Puig, S. Sauleda)

Main Article

Table 2

Clinical characteristics and risk factors for HEV infection reported by HEV RNA‒positive donors, Catalonia, Spain*

Characteristic
 No. (%) responses, n = 111
Symptoms or clinical signs
Symptom of acute hepatitis: aches, nausea, abdominal pain, vomiting 2 (1.8)
General unrest 27 (24.3)
Dark urine or light stool
 17 (15.3)
Information on diet: eating habits related with HEV acquisition
Vegetarian or vegan 1 (0.9)
Usual consumption of undercooked meat 47 (42.3)

*HEV, hepatitis E virus. †96 HEV RNA‒positive donors responded to these questions.

Main Article

Page created: October 13, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external